ABBOTT LABORATORIES: operating_income
| Value | {"amount": 1564000000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | ABBOTT LABORATORIES |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-18T21:32:10.851947+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1e53a3a8-cbe9-4ee4-8205-32946b5a66ca
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-19-000624Retrieved: 2026-08-18T21:32:10.851947+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000001800/operating-income/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1e53a3a8-cbe9-4ee4-8205-32946b5a66ca
History
- supersedes {"amount": 1726000000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001047469-18-000856)